Share on LinkedInShare on LinkedIn

ARTICLE · 22 JUNE 2023

Second Circuit Upholds Dismissal Of AstraZeneca Investor Suit

On May 16, 2023, the US Court of Appeals for the Second Circuit affirmed the Southern District of New York's order dismissing an action brought by investors of AstraZeneca PLC...

United StatesLitigation, Mediation & Arbitration

Second Circuit Upholds Dismissal of AstraZeneca Investor Suit; Southern District of New York Dismisses Stockholder Suit Against Array Technologies; Eastern District of New York Tosses Stockholder Class Action Based on Ericsson Bribery Investigation

Second Circuit Upholds Dismissal of AstraZeneca Investor Suit

On May 16, 2023, the US Court of Appeals for the Second Circuit affirmed the Southern District of New York's order dismissing an action brought by investors of AstraZeneca PLC (AstraZeneca) attempting to hold the company liable for alleged misstatements regarding enrollment in its clinical trials for a COVID-19 vaccine candidate. The group of investors brought claims against AstraZeneca under Section 10(b) of the Securities Exchange Act of 1934 (the Exchange Act).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from